YONGHE MEDICAL (02279) saw its shares surge more than 18% during the trading session, reaching a high of HK$2.1, marking its highest level since October of last year. As of the time of writing, the stock was up 13.79%, trading at HK$1.98, with a turnover of HK$2.2049 million.

On the news front, it was reported that on the afternoon of January 20th, Benoît Recorbom, the Medical Officer and Regional Health Head of the French Embassy in China, along with embassy medical team member Agathe Osterno, visited YONGHE Hair Transplantation's Beijing headquarters. They experienced services such as AI scalp detection and scalp maintenance, gaining a detailed understanding of YONGHE's advantages and leading position in the fields of hair transplantation and hair care.

Zhang Hui, Senior Vice President of YONGHE MEDICAL, stated that the Beijing headquarters, located in the Dongdaqiao area near the embassy district, benefits from both its prime location and expertise in hair medicine, and is committed to providing quality hair medical services to embassy staff. Both parties expressed a willingness to explore deeper cooperation in the future.

Financial reports indicate that in the first half of this year, YONGHE MEDICAL achieved revenue of RMB 862 million. Profit attributable to shareholders was RMB 27.913 million, representing a turnaround from a loss to a profit compared to the same period last year.

As of June 30, 2025, the company operated 63 hair transplantation medical institutions across 61 cities in China, along with 6 Svenson Hair Health centers in Shenzhen, Shanghai, and Guangzhou, establishing it as the largest and most geographically widespread chain hair medical group in the country. In the six months ended June 30, 2025, the company served a total of 64,845 consumers.

CICC previously noted that optimized store network layout coupled with refined marketing strategies are enhancing operational efficiency and profitability.